Post-Test - Advances in DMTs
Please choose the best answer for the question below then click the button at the bottom to proceed.
Which of the following pairs correctly matches an investigational disease-modifying therapy with its therapeutic target?
Evobrutinib; sphingosine-1 phosphate receptor
Temelimab; human endogenous retrovirus